COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03071172
Recruitment Status : Unknown
Verified February 2017 by GeneScience Pharmaceuticals Co., Ltd..
Recruitment status was:  Not yet recruiting
First Posted : March 6, 2017
Last Update Posted : March 6, 2017
Peking University Third Hospital
The First Affiliated Hospital with Nanjing Medical University
Women's Hospital School Of Medicine Zhejiang University
Xiangya Hospital of Central South University
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The First Affiliated Hospital of Anhui Medical University
Information provided by (Responsible Party):
GeneScience Pharmaceuticals Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : May 2018